Wedbush Initiates Coverage On Sionna Therapeutics with Outperform Rating, Announces Price Target of $53

Benzinga Newsdesk www.benzinga.com Neutral 54.3%

Neg 0% Neu 54.3% Pos 0%

Wedbush analyst Laura Chico initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Outperform rating and announces Price Target of $53.